Disc Medicine, Inc. (IRON)
(Delayed Data from NSDQ)
$51.74 USD
+1.39 (2.76%)
Updated Sep 9, 2024 04:00 PM ET
After-Market: $51.75 +0.01 (0.02%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
IRON 51.74 +1.39(2.76%)
Will IRON be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for IRON based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for IRON
Biotech Stock Roundup: IRON, VERV Down on Study Updates, BMYs Drug News & More
Disc Medicine (IRON) Down on Mixed Results From AURORA Study
IRON: What are Zacks experts saying now?
Zacks Private Portfolio Services
How Much Upside is Left in Disc Medicine, Inc. (IRON)? Wall Street Analysts Think 38.17%
Recent Price Trend in Disc Medicine, Inc. (IRON) is Your Friend, Here's Why
Here's Why Disc Medicine, Inc. (IRON) Is a Great 'Buy the Bottom' Stock Now
Other News for IRON
Disc Medicine to Participate in Upcoming Investor Conferences
TJX downgraded, Crocs upgraded: Wall Street's top analyst calls
Disc Medicine initiated with bullish view at Wells Fargo, here's why
Disc Medicine Breaks Above 200-Day Moving Average - Bullish for IRON
Analysts Offer Insights on Healthcare Companies: Immunocore Holdings (IMCR), Natera (NTRA) and Disc Medicine (IRON)